Table 1

Patient characteristics
Age, yr, median (IQR) 65 (48.0-73.0)
PSA level, ng/ml, median (IQR) 7.2 (2.1-20.3)
Biopsy Gleason Score, n.
6 12 (22%)
7 30 (53%)
8-10 14 (25%)
Clinical Stage, n.
cT1c 25 (44.8%)
cT2a-b 30 (53.7%)
cT3 1 (1.5%)
Pathological Gleason Score, n.
6 2 (3.5%)
7 44 (78.5%)
8-10 10 (18.0%)
Pathological Stage, n.
cT1c 42 (74.7%)
cT2a-b 13 (23.1%)
cT3 1 (2.2%)
Pathological positive lymph node, n. 9 (16%)
Positive surgical margins, n. 8 (14%)

IQR = Interquartile range.

Cristini et al.

Cristini et al. BMC Urology 2013 13:13   doi:10.1186/1471-2490-13-13

Open Data